Kenneth Paul Hagen serves as Executive at ALBANY MOLECULAR RESEARCH INC, where they oversee executive responsibilities. Since joining the company, Kenneth Paul Hagen has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2017 involved selling 6,838 shares valued at $148.7K.
Kenneth Paul Hagen currently holds 3,036 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Paul Hagen has been a net neutral trader of AMRI stock. They have purchased $0 and sold $0 worth of shares.
Kenneth Paul Hagen's most recent insider trade was on Aug 31, 2017, when they sold 6,838 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| $14.82 |
| Discretionary |